treatment of excitotoxic neurodegeneration. Curr Med Chem-Central Nervous System Agents 5: 207–216. 25. Aramburu J, Garcia-Co´zar F, Raghavan A, Okamura H, Rao A, et al. (1998) Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol Cell 5: 627–637. 26. Noguchi H, Matsushita M, Okitsu T, Moriwaki A, Tomizawa K, et al. (2004) A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 10: 305–309. 27. Bennin DA, Don AS, Brake T, McKenzie JL, Rosenbaum H, et al. (2002) Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B’ subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest. J Biol Chem 277: 27449–27467. 28. Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, et al. (1987) Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation 43: 197–204. 29. Rutz B, Se´raphin B (2000) A dual role for BBP/ScSF1 in nuclear pre-mRNA retention and splicing. EMBO J 19: 1873–1886. 30. Hillman RT, Green RE, Brenner SE (2004) An unappreciated role for RNA surveillance. Genome Biol 5: R8. 31. Li Y, Bor Y, Misawa Y, Xue Y, Rekosh D, et al. (2006) An intron with a constitutive transport element is retained in a Tap messenger RNA. Nature 443: 234–237. 32. Galante PAF, Sakabe NJ, Kirschbaum-Slager N, Jose´ de Souza S (2004) Detection and evaluation of intron retention events in the human transcriptome. RNA 10: 757–765. Calcineurin Activation and Hair Development 33. Bell TJ, Miyashiro KY, Sul J, McCullough R, Buckley PT, et al. (2008) Cytoplasmic BKCa channel intron-containing mRNAs contribute to the intrinsic excitability of hippocampal neurons. Proc Natl Acad Sci USA 105: 1901–1906. 34. Dennis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, et al. (2005) Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelet. Cell 122: 379–391. 35. Lin CG, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, et al. (1998) Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20: 589–602. 36. Taniguchi I, Masuyama K, Ohno M (2007) Role of purine-rich exonic splicing enhancers in nuclear retention of pre-mRNAs. Proc Natl Acad Sci USA 104: 13684–13689. 37. Tarr´ıo R, Ayala FJ, Rodr´ıguez-Trelles F (2008) Alternative splicing: a missing piece in the puzzle of intron gain. Proc Natl Acad Sci, USA 105: 7223–7228. 38. Hogan PG, Chen L, Nardone J, Rao A (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17: 2205–2232. 39. Burkard N, Becher J, Heindl C, Neyses L, Schuh K, et al. (2005) Targeted proteolysis sustains calcineurin activation. Circulation 111: 1045–1053. 40. Guerini D, Klee CB (1989) Cloning of human calcineurin A: evidence for two isozymes and identification of a polyproline structural domain. Proc Natl Acad Sci USA 86: 9183–9187. 41. Lara-Pezzi E, Winn N, Paul A, McCullagh K, Slominsky E, et al. (2007) A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration. J Cell Biol 179: 1205–1218. 42. Mu¨ller-R o¨ver S, Handjiski B, van der Veen C, Eichmu¨ ller S, Foitzik K, et al. (2001) A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 117: 3–15. PLoS ONE | www.plosone.org 12 March 2011 | Volume 6 | Issue 3 | e17685